Exercise-induced muscle injury is one of the most common types of sports injuries. Skeletal muscle troponin I (skTnI) serves as an ideal biomarker in assessing such injuries, facilitating timely detection and evaluation. In this study, we develop a fluorescent sandwich lateral flow immunoassay (LFIA) combined with a desktop analyzer for rapid detection of skTnI. Through optimizing the reaction system, the assay achieves a satisfying detection performance, reaching a limit of detection (LOD) of 0.5 ng/mL with a turnaround time of 15 min. The proposed detection platform offers portability, ease of use, and high sensitivity, which facilitates the monitoring of exercise-induced muscle injuries at the point of care. This feature is particularly advantageous for end users, enabling timely detection of sports-related injuries and ultimately enhancing prognosis and sports life.
Exercise-induced muscle injury is one of the most common types of sports injuries. Skeletal muscle troponin I (skTnI) serves as an ideal biomarker in assessing such injuries, facilitating timely detection and evaluation. In this study, we develop a fluorescent sandwich lateral flow immunoassay (LFIA) combined with a desktop analyzer for rapid detection of skTnI. Through optimizing the reaction system, the assay achieves a satisfying detection performance, reaching a limit of detection (LOD) of 0.5 ng/mL with a turnaround time of 15 minutes. The proposed de-tection platform offers portability, ease of use, and high sensitivity, which facilitates the moni-toring of exercise-induced muscle injuries at the point of care. This feature is particularly advan-tageous for end-users, enabling timely detection of sports-related injuries and ultimately en-hancing prognosis and sports life.
Respiratory fungal infections are challenging to diagnose due to non-specific symptoms and limitations of conventional methods. This study established an integrated, rapid workflow for detecting three common pathogenic fungi, combining an optimized nucleic acid extraction method with a TaqMan-based multiplex real-time qPCR system. The high-salt lysis method yielded high-purity nucleic acid extracts, with performance comparable to or better than commercial kits. The multiplex qPCR assay was optimized for high specificity, sensitivity, and reproducibility, with detection limits as low as 10 CFU/mL for some fungi. Clinical validation using 14 sputum samples demonstrated high agreement with conventional culture, and the assay detected a low-load infection missed by culture. This integrated approach shows great potential for rapid, sensitive, and specific clinical detection of respiratory fungal infections.